The prognostic values of matrix metalloproteinases in ovarian cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The prognostic values of matrix metalloproteinases in ovarian cancer
Authors
Keywords
-
Journal
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
Volume -, Issue -, Pages 030006051982598
Publisher
SAGE Publications
Online
2019-05-17
DOI
10.1177/0300060519825983
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A pathology atlas of the human cancer transcriptome
- (2017) Mathias Uhlen et al. SCIENCE
- Prognostic value of MMP-2 for patients with ovarian epithelial carcinoma: a systematic review and meta-analysis
- (2016) Honglei Jia et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients
- (2016) Fee Klupp et al. BMC CANCER
- miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
- (2016) András Lánczky et al. BREAST CANCER RESEARCH AND TREATMENT
- The Expression and Significance of CXCR5 and MMP-13 in Colorectal Cancer
- (2015) Qin Yan et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis
- (2015) Patrice Desmeules et al. HUMAN PATHOLOGY
- The Expression of Tumor-Derived and Stromal-Derived Matrix Metalloproteinase 2 Predicted Prognosis of Ovarian Cancer
- (2015) Ziyi Fu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Knockdown of MMP12 inhibits the growth and invasion of lung adenocarcinoma cells
- (2015) F-Z Lv et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Matrix metalloproteinase-12 expression is increased in cutaneous melanoma and associated with tumor aggressiveness
- (2015) Zixi Zhang et al. TUMOR BIOLOGY
- Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer
- (2015) Ga-Eon Kim et al. BMC CANCER
- Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis
- (2015) Fanghui Ren et al. PLoS One
- Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma
- (2014) I-Che Chung et al. BMC CANCER
- Overexpression ofMMP13Is Associated with Clinical Outcomes and Poor Prognosis in Oral Squamous Cell Carcinoma
- (2014) Vui King Vincent-Chong et al. TheScientificWorldJOURNAL
- Expression and clinical significance of matrix metalloproteinase-17 and -25 in gastric cancer
- (2014) YING WANG et al. Oncology Letters
- MMPs in Ovarian Cancer as Therapeutic Targets
- (2012) Amer Karam et al. Anti-Cancer Agents in Medicinal Chemistry
- Matrix metalloproteinase-12 is associated with overall survival in Chinese patients with gastric cancer
- (2012) Jianyong Zheng et al. JOURNAL OF SURGICAL ONCOLOGY
- Increased expression of matrix metalloproteinase-13 in glioma is associated with poor overall survival of patients
- (2012) Jun Wang et al. MEDICAL ONCOLOGY
- Expression of MMP-2, −7, −9, MT1-MMP and TIMP-1 and −2 has no prognostic relevance in patients with advanced epithelial ovarian cancer
- (2011) JEAN-LUC BRUN et al. ONCOLOGY REPORTS
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
- (2010) MP Coleman et al. LANCET
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer
- (2008) Heikki Luukkaa et al. ACTA OTO-LARYNGOLOGICA
- Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognosis of invasive breast cancer
- (2008) Bin Zhang et al. BMC CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started